Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15048013rdf:typepubmed:Citationlld:pubmed
pubmed-article:15048013lifeskim:mentionsumls-concept:C0999699lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0040578lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0022245lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0288250lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0035028lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:15048013lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:15048013pubmed:issue6lld:pubmed
pubmed-article:15048013pubmed:dateCreated2004-3-31lld:pubmed
pubmed-article:15048013pubmed:abstractTextWe examined the contribution of large-conductance, Ca(2+)-sensitive K+ (MaxiK) channel to beta2-adrenoceptor-activated relaxation to isoprenaline in guinea-pig tracheal smooth muscle focusing on the role for cAMP in the coupling between beta2-adrenoceptor and MaxiK channel. Isoprenaline-elicited relaxation was confirmed to be mediated through beta2-type of adrenoceptor since the response was antagonized in a competitive fashion by a beta2-selective adrenoceptor antagonist butoxamine with a pA2 value of 6.56. Isoprenaline-induced relaxation was significantly potentiated by a selective inhibitor of cyclic AMP-specific phosphodiesterase, Ro-20-1724 (0.1-1 microM). cAMP-dependent mediation of MaxiK channel in the relaxant response to isoprenaline was evidenced since the potentiated response to isoprenaline by the presence of Ro-20-1724 (1 microM) was inhibited by the channel selective blocker, iberiotoxin (IbTx, 100 nM). This concept was supported by the finding that the relaxation to a membrane permeable cAMP analogue, 8-bromo-cAMP (1 mM), was susceptible to the inhibition by IbTx. On the other hand, isoprenaline-induced relaxation was not practically diminished by an adenylyl cyclase inhibitor SQ 22,536 (100 microM). However, isoprenaline-induced relaxation in the presence of SQ 22,536 was suppressed by IbTx. Characteristics of isoprenaline-induced relaxant response, i.e., impervious to SQ 22,536 but susceptible to IbTx, were practically mimicked by cholera toxin (CTX, 5 microg/ml), an activator of adenylyl cyclase coupled-heterotrimeric guanine nucleotide-binding regulatory protein Gs. These findings indicate that in guinea-pig tracheal smooth muscle: 1) MaxiK channel substantially mediates beta2-adrenoceptor-activated relaxation; 2) both cAMP-dependent and -independent mechanisms underlie the functional coupling between beta2-adrenoceptor and MaxiK channel to induce muscle relaxation; and 3) direct regulation of MaxiK channel by Gs operates in cAMP-independent coupling between beta2-adrenoceptor and this ion channel.lld:pubmed
pubmed-article:15048013pubmed:languageenglld:pubmed
pubmed-article:15048013pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:citationSubsetIMlld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15048013pubmed:statusMEDLINElld:pubmed
pubmed-article:15048013pubmed:monthDeclld:pubmed
pubmed-article:15048013pubmed:issn0916-8737lld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:TanakaYoshioYlld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:ShigenobuKoki...lld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:KoikeKatsuoKlld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:YamashitaYoko...lld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:HorinouchiTak...lld:pubmed
pubmed-article:15048013pubmed:authorpubmed-author:YamakiFumikoFlld:pubmed
pubmed-article:15048013pubmed:issnTypePrintlld:pubmed
pubmed-article:15048013pubmed:volume39lld:pubmed
pubmed-article:15048013pubmed:ownerNLMlld:pubmed
pubmed-article:15048013pubmed:authorsCompleteYlld:pubmed
pubmed-article:15048013pubmed:pagination205-19lld:pubmed
pubmed-article:15048013pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:meshHeadingpubmed-meshheading:15048013...lld:pubmed
pubmed-article:15048013pubmed:year2003lld:pubmed
pubmed-article:15048013pubmed:articleTitleMaxiK channel mediates beta2-adrenoceptor-activated relaxation to isoprenaline through cAMP-dependent and -independent mechanisms in guinea-pig tracheal smooth muscle.lld:pubmed
pubmed-article:15048013pubmed:affiliationDepartment of Chemical Pharmacology, Toho University School of Pharmaceutical Sciences, Miyama 2-2-1, Funabashi-City, Chiba 274-8510, Japan. yotanaka@phar.toho-u.ac.jplld:pubmed
pubmed-article:15048013pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15048013pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:15048013pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15048013lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15048013lld:pubmed